A longitudinal investigation of posttraumatic growth and its associated factors among head and neck cancer survivors

Hamdan, Nur Amirah; Hamid, Norhaliza Abd; Abdullah, Mohammad Farris Iman Leong Bin

doi:10.1002/pon.5835

Cited by 6 publications

(5 citation statements)

References 30 publications

(66 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite the difficulties of the pandemic scenario, and any negative implications for oncological patients, in our sample we observed an improvement in distress and development of PTG similar to what has been observed in the literature concerning other diseases ( Gori et al, 2021 ; Hamdan et al, 2022 ). As observed in other studies ( Chiesi et al, 2022 ), resilience and PTG are positively correlated, showing how the presence of adaptive and psychological recovery strategies could improve the ability to transform a traumatic event into a resource.…”

Section: Discussionsupporting

confidence: 87%

Post-traumatic growth in oncological patients during the COVID-19 pandemic

Lafuenti,

Dinapoli,

Mastrilli

et al. 2023

Health Psychology Report

View full text Add to dashboard Cite

BackgroundPost-traumatic growth (PTG) is defined as “positive psychological change experienced as a result of the struggle with high-ly challenging life circumstances”. Diagnosis of cancer leads to many psychological challenges. The recent pandemic forced oncological patients to face other multiple stressors. Resilience is a target of interest for PTG. The aim of this study is to analyze relationships between cancer trauma, COVID-19 pandemic stress, PTG and resilience over time.Participants and procedureOne hundred forty-six patients (124 females, 22 males) in active oncological treatment were enrolled from September 2020: 45.2% (n = 66) diagnosed with gynecological cancer, 23.3% (n = 34) with breast cancer, 15.1% (n = 22) with lung cancer, 16.5% (n = 24) with other cancers. We conducted a prospective longitudinal study on oncological patients evaluated at: diag-nosis (T0), 6 (T1) and 12 months (T2) by means of the following self-administered tests: Distress Thermometer (DT), Hospi-tal Anxiety and Depression Scale (HADS), Impact of Event Scale Revised (IES-R), Post-traumatic Growth Inventory (PTGI), Perceived Stress Scale (PSS), Connor-Davidson Resilience Scale (CD-RISC).ResultsDT decreased over time (T0 vs. T2, p < .001). HADS decreased from T0 to T2 (p < .001). The PTG subscales regarding new possibilities and appreciating life improved comparing T0 vs. T2 (p = .029; p = .013), as well as the total index of PTG (p = .027). The IES avoidance subscale score decreased over time (T0 vs. T1, p = .035).ConclusionsFor some patients, the cancer experience is characterized not only by psychological distress but also by the presence and growth of positive aspects, such as the tendency to positively reconsider the value and importance of life, health and social relationships.

show abstract

Section: Discussionsupporting

confidence: 87%

Post-traumatic growth in oncological patients during the COVID-19 pandemic

Lafuenti,

Dinapoli,

Mastrilli

et al. 2023

Health Psychology Report

View full text Add to dashboard Cite

show abstract

“…However, it should be noted that not all patients with trauma related to living with cancer could trigger the development of PTG. If the traumatic experience of living with cancer is too intense, it may lead to failure for cognitive reprocessing of the traumatic event to search for meaning, which will hamper the development of PTG [ 17 ]. Hence, it is pivotal to investigate psychosocial intervention which effectively facilitate the development of PTG.…”

Section: Introductionmentioning

confidence: 99%

Acceptance and commitment therapy versus mindfulness-based stress reduction for newly diagnosed head and neck cancer patients: A randomized controlled trial assessing efficacy for positive psychology, depression, anxiety, and quality of life

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background and aim Head and neck cancer patients are vulnerable to various psychological complications due to the effects of both cancer itself and cancer treatment on patients’ appearance and physical well-being. Nevertheless, few data have been obtained on effective psychosocial interventions that could protect this group of cancer patients’ psychological well-being. Therefore, this three-armed, parallel-group, double-blind, randomized control trial (RCT) aims to evaluate and compare the effects of acceptance and commitment therapy (ACT) and mindfulness-based stress reduction (MBSR) on positive psychology (such as posttraumatic growth [PTG], hope, and optimism), quality of life (QoL), and psychological complications (depression, anxiety, and experiential avoidance) among newly diagnosed head and neck cancer patients. Methods and analysis This RCT will target newly diagnosed head and neck cancer patients who have been treated only with surgery or who have not yet received any treatment. In total, 120 patients who meet all of the study’s inclusion criteria and none of its exclusion criteria will be randomly assigned into three groups—an ACT group, an MBSR group, and a treatment-as-usual control group—at a 1:1:1 allocation ratio. Participants in the two intervention groups (the ACT and MBSR groups) will undergo an eight-week group intervention program. During this program, each intervention will comprise eight modules based on ACT and MBSR, respectively. Outcome assessments will be performed across a three-point timeline, including before the intervention (t0), immediately after the psychosocial intervention at eight weeks (t1), and six months after the intervention (t2). The primary outcome that will be assessed during this RCT is PTG. Meanwhile, the secondary outcomes that will be evaluated in this study are such as QoL, hope, optimism, depression, anxiety, and experiential avoidance. Trial registration number NCT04800419 (ClinicalTrials.gov). Registered on March 16, 2021.

show abstract

“…The patient-reported content validity index scores were excellent, and weak bidirectional correlations were found with resilience, depression, and anxiety. Another study found that lower QoL scores at diagnosis and during the first year after diagnosis have a predictive value for patients with head and neck squamous cell carcinoma, independent of other factors, predicting lower overall survival [2,3], and another study examined the correlation between three commonly used instruments for assessing the quality of life of 33 head and neck cancer patients at Mato Grosso Cancer Hospital in Brazil, revealing a positive correlation [31,38,39]. None of the studies did predictive analysis.…”

Section: Discussionmentioning

confidence: 99%

Light gradient boosting-based prediction of quality of life among oral cancer-treated patients

Ramalingam,

Yadalam,

Ramani

et al. 2024

BMC Oral Health

View full text Add to dashboard Cite

Background and introduction Statisticians rank oral and lip cancer sixth in global mortality at 10.2%. Mouth opening and swallowing are challenging. Hence, most oral cancer patients only report later stages. They worry about surviving cancer and receiving therapy. Oral cancer severely affects QOL. QOL is affected by risk factors, disease site, and treatment. Using oral cancer patient questionnaires, we use light gradient Boost Tree classifiers to predict life quality. Methods DIAS records were used for 111 oral cancer patients. The European Organisation for Research and Treatment of Cancer’s QLQ-C30 and QLQ-HN43 were used to document the findings. Anyone could enroll, regardless of gender or age. The IHEC/SDC/PhD/OPATH-1954/19/TH-001 Institutional Ethical Clearance Committee approved this work. After informed consent, patients received the EORTC QLQ-C30 and QLQ-HN43 questionnaires. Surveys were in Tamil and English. Overall, QOL ratings covered several domains. We obtained patient demographics, case history, and therapy information from our DIAS (Dental Information Archival Software). Enrolled patients were monitored for at least a year. After one year, the EORTC questionnaire was retaken, and scores were recorded. This prospective analytical exploratory study at Saveetha Dental College, Chennai, India, examined QOL at diagnosis and at least 12 months after primary therapy in patients with histopathologically diagnosed oral malignancies. We measured oral cancer patients’ quality of life using data preprocessing, feature selection, and model construction. A confusion matrix was created using light gradient boosting to measure accuracy. Results Light gradient boosting predicted cancer patients’ quality of life with 96% accuracy and 0.20 log loss. Conclusion Oral surgeons and oncologists can improve planning and therapy with this prediction model.

show abstract

A longitudinal investigation of posttraumatic growth and its associated factors among head and neck cancer survivors

Cited by 6 publications

References 30 publications

Post-traumatic growth in oncological patients during the COVID-19 pandemic

Post-traumatic growth in oncological patients during the COVID-19 pandemic

Acceptance and commitment therapy versus mindfulness-based stress reduction for newly diagnosed head and neck cancer patients: A randomized controlled trial assessing efficacy for positive psychology, depression, anxiety, and quality of life

Light gradient boosting-based prediction of quality of life among oral cancer-treated patients

Contact Info

Product

Resources

About